TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Transfer Modality Research Initiative - Bangladesh
Brief Summary: This is a randomized control trial in two zones of Bangladesh (north and south). Treatment is assigned at the village level where treatments are: cash transfers (north and south); cash transfers + nutrition behavior communication change (north only); food transfers (north and south); food transfers + nutrition behavior communication change (south only); food-cash split (north and south); and controls (north and south). Within treatment localities, women living in very poor households are targeted to receive benefits for two years.


Options:
A: Arm Label: Cash transfer; Type: EXPERIMENTAL; Interventions: Other: Cash transfer | Arm Label: Food transfer; Type: EXPERIMENTAL; Interventions: Other: Food transfer | Arm Label: Food and cash transfer; Type: EXPERIMENTAL; Interventions: Other: Food and cash transfer | Arm Label: Cash transfer + BCC; Type: EXPERIMENTAL; Interventions: Other: Cash transfer, Behavioral: Behavior Communication Change (BCC) | Arm Label: Food transfer + BCC; Type: EXPERIMENTAL; Interventions: Other: Food transfer, Behavioral: Behavior Communication Change (BCC) | Intervention Type: OTHER; Name: Cash transfer; Assigned to Arm(s): Cash transfer, Cash transfer + BCC | Intervention Type: OTHER; Name: Food transfer; Assigned to Arm(s): Food transfer, Food transfer + BCC | Intervention Type: OTHER; Name: Food and cash transfer; Assigned to Arm(s): Food and cash transfer | Intervention Type: BEHAVIORAL; Name: Behavior Communication Change (BCC); Assigned to Arm(s): Cash transfer + BCC, Food transfer + BCC
B: Arm Label: Treatment; Type: EXPERIMENTAL; Interventions: Other: Childhood Obesity | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Childhood Obesity; Assigned to Arm(s): Treatment
C: Intervention Type: BEHAVIORAL; Name: Physical activity and diet; Assigned to Arm(s): N/A
D: Arm Label: parent-targeted intervention; Type: EXPERIMENTAL; Interventions: Behavioral: multi-component/setting parent-targeted intervention | Arm Label: Primary Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: multi-component/setting parent-targeted intervention; Assigned to Arm(s): parent-targeted intervention

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase I Study of the Safety and Immunogenicity of Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine RSV LID ΔM2-2 in RSV-Seronegative Infants and Children
Brief Summary: Respiratory syncytial virus (RSV) is a common cause of illness in infants and children around the world. This study will evaluate the safety and immune response to an RSV vaccine in RSV-seronegative infants and children.

This study is a companion study to CIR 291.


Options:
A: Arm Label: RSV LID ΔM2-2 Vaccine; Type: EXPERIMENTAL; Interventions: Biological: RSV LID ΔM2-2 Vaccine | Arm Label: Placebo Vaccine; Type: PLACEBO_COMPARATOR; Interventions: Biological: Placebo Vaccine | Intervention Type: BIOLOGICAL; Name: RSV LID ΔM2-2 Vaccine; Assigned to Arm(s): RSV LID ΔM2-2 Vaccine | Intervention Type: BIOLOGICAL; Name: Placebo Vaccine; Assigned to Arm(s): Placebo Vaccine
B: Arm Label: Placebo + Inactivated Influenza Vaccine (IIV); Type: ACTIVE_COMPARATOR; Interventions: Biological: IIV, Other: Placebo | Arm Label: MEDI7510 + IIV; Type: EXPERIMENTAL; Interventions: Biological: MEDI7510, Biological: IIV | Intervention Type: BIOLOGICAL; Name: MEDI7510; Assigned to Arm(s): MEDI7510 + IIV | Intervention Type: BIOLOGICAL; Name: IIV; Assigned to Arm(s): MEDI7510 + IIV, Placebo + Inactivated Influenza Vaccine (IIV) | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Placebo + Inactivated Influenza Vaccine (IIV)
C: Arm Label: Group 1 Standard; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Group 2 Enhanced Standard; Type: ACTIVE_COMPARATOR; Interventions: Other: Supplemental training, education and hygiene | Arm Label: Group 3 Chlorhexidine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Chlorhexidine gluconate, Other: Supplemental training, education and hygiene | Intervention Type: DRUG; Name: Chlorhexidine gluconate; Assigned to Arm(s): Group 3 Chlorhexidine | Intervention Type: OTHER; Name: Supplemental training, education and hygiene; Assigned to Arm(s): Group 2 Enhanced Standard, Group 3 Chlorhexidine
D: Arm Label: RSV D46/NS2/N/ΔM2-2-HindIII Vaccine; Type: EXPERIMENTAL; Interventions: Biological: D46/NS2/N/ΔM2-2-HindIII | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Biological: Placebo | Intervention Type: BIOLOGICAL; Name: D46/NS2/N/ΔM2-2-HindIII; Assigned to Arm(s): RSV D46/NS2/N/ΔM2-2-HindIII Vaccine | Intervention Type: BIOLOGICAL; Name: Placebo; Assigned to Arm(s): Placebo

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomized Comparison of MynxGrip Vascular Closure Device and Manual Compression for Closure After Femoral Access Angiography. The Closure Devices Used in Every Day Practice Study, CLOSE-UP III Trial
Brief Summary: Is the MynxGrip (test device) non-inferior to manuel compression (standard comparator) in the incidence of adverse access site related events in-hospital, at 30 days and at 6 months.


Options:
A: Arm Label: FemoSeal®; Type: EXPERIMENTAL; Interventions: Device: FemoSeal® | Arm Label: Manual compression; Type: ACTIVE_COMPARATOR; Interventions: Other: Manual compression | Intervention Type: DEVICE; Name: FemoSeal®; Assigned to Arm(s): FemoSeal® | Intervention Type: OTHER; Name: Manual compression; Assigned to Arm(s): Manual compression
B: Arm Label: Manual Compression; Type: ACTIVE_COMPARATOR; Interventions: Other: Manual Compression | Arm Label: Vascular Closure Device; Type: EXPERIMENTAL; Interventions: Device: Vascular Closure Device | Intervention Type: OTHER; Name: Manual Compression; Assigned to Arm(s): Manual Compression | Intervention Type: DEVICE; Name: Vascular Closure Device; Assigned to Arm(s): Vascular Closure Device
C: Arm Label: Manuel compression; Type: ACTIVE_COMPARATOR; Interventions: Other: Manual compression | Arm Label: MynxGrip closure device; Type: EXPERIMENTAL; Interventions: Device: MynxGrip | Intervention Type: DEVICE; Name: MynxGrip; Assigned to Arm(s): MynxGrip closure device | Intervention Type: OTHER; Name: Manual compression; Assigned to Arm(s): Manuel compression
D: Arm Label: FemoSeal®; Type: EXPERIMENTAL; Interventions: Device: FemoSeal® | Arm Label: ExoSeal®; Type: EXPERIMENTAL; Interventions: Device: ExoSeal® | Arm Label: Manual compression; Type: ACTIVE_COMPARATOR; Interventions: Other: Manual compression | Intervention Type: DEVICE; Name: FemoSeal®; Assigned to Arm(s): FemoSeal® | Intervention Type: DEVICE; Name: ExoSeal®; Assigned to Arm(s): ExoSeal® | Intervention Type: OTHER; Name: Manual compression; Assigned to Arm(s): Manual compression

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Cognitive Benefits of Interactive Mental and Physical Exercise for Older Adults at Risk for or With Mild Cognitive Impairment (MCI)
Brief Summary: The purpose of this study is to clarify the benefits to brain health and thinking processes that result from different forms of exercise. This study will examine the effectiveness of cybercycling (virtual reality enhanced stationary cycling) for persons at risk for and with MCI, and compare this with the individual cognitive, behavioral, and physiological effects of physical and mental exercise alone. The Investigators hypothesis that cognitive benefit will be greatest for combined aerobic and cognitive exercise compared to physical and mental exercise alone.


Options:
A: Arm Label: Cybercycle-Game; Type: EXPERIMENTAL; Interventions: Behavioral: Cybercycle-Game | Arm Label: Cybercyle-Tour; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Cybercyle-Tour | Arm Label: Game Only; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Game Only | Intervention Type: BEHAVIORAL; Name: Cybercycle-Game; Assigned to Arm(s): Cybercycle-Game | Intervention Type: BEHAVIORAL; Name: Cybercyle-Tour; Assigned to Arm(s): Cybercyle-Tour | Intervention Type: BEHAVIORAL; Name: Game Only; Assigned to Arm(s): Game Only
B: Arm Label: Intervention group; Type: EXPERIMENTAL; Interventions: Device: Computerised cognitive training using virtual reality | Arm Label: Control Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Computerised cognitive training using virtual reality; Assigned to Arm(s): Intervention group
C: Arm Label: Cybercycling; Type: EXPERIMENTAL; Interventions: Behavioral: Cybercycling | Arm Label: Traditional Stationary Biking; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Traditional exercise | Intervention Type: BEHAVIORAL; Name: Cybercycling; Assigned to Arm(s): Cybercycling | Intervention Type: BEHAVIORAL; Name: Traditional exercise; Assigned to Arm(s): Traditional Stationary Biking
D: Arm Label: Intervention Group - Exergame Training; Type: EXPERIMENTAL; Interventions: Behavioral: Exergame training according to the 'Brain-IT' exergame-based training concept | Arm Label: Usual Care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Usual Care | Intervention Type: BEHAVIORAL; Name: Exergame training according to the 'Brain-IT' exergame-based training concept; Assigned to Arm(s): Intervention Group - Exergame Training | Intervention Type: BEHAVIORAL; Name: Usual Care; Assigned to Arm(s): Usual Care

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Improving Quality of Life in Nursing Home Residents: A Cluster Randomized Clinical Trial of Efficacy (The KOSMOS Study)
Brief Summary: Improving quality of life (QoL) in residents of nursing homes:

A cluster randomized clinical trial of efficacy - The KOSMOS study.

COSMOS (COmmunication (Advance Care Planning - ACP), Systematic pain assessment and treatment, Medication review, Occupational therapy, and Safety) is a practical intervention aimed to improve clinical and psychiatric challenges in NH patients. The COSMOS intervention combines the most effective research results to improve staff competence and patients' mental health, safety, QoL. We also aim to reduce psychotropic drug use and costs.


Options:
A: Arm Label: Person-centered Care; Type: EXPERIMENTAL; Interventions: Other: Person-centered Care, Other: Optimised Treatment | Arm Label: Optimised Treatment; Type: ACTIVE_COMPARATOR; Interventions: Other: Optimised Treatment | Intervention Type: OTHER; Name: Person-centered Care; Assigned to Arm(s): Person-centered Care | Intervention Type: OTHER; Name: Optimised Treatment; Assigned to Arm(s): Optimised Treatment, Person-centered Care
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: TREA (Treatment Routes for Exploring Agitation) | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Placebo Control Group | Intervention Type: BEHAVIORAL; Name: TREA (Treatment Routes for Exploring Agitation); Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Placebo Control Group; Assigned to Arm(s): 2
C: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Intervention; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Communication, Behavioral: Systematic Pain Assessment and Treatment, Behavioral: Medication Review, Behavioral: Occupational therapy, Behavioral: Safety | Intervention Type: BEHAVIORAL; Name: Communication; Assigned to Arm(s): Intervention | Intervention Type: BEHAVIORAL; Name: Systematic Pain Assessment and Treatment; Assigned to Arm(s): Intervention | Intervention Type: BEHAVIORAL; Name: Medication Review; Assigned to Arm(s): Intervention | Intervention Type: BEHAVIORAL; Name: Occupational therapy; Assigned to Arm(s): Intervention | Intervention Type: BEHAVIORAL; Name: Safety; Assigned to Arm(s): Intervention
D: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: Pimavanserin 40 mg; Type: EXPERIMENTAL; Interventions: Drug: Pimavanserin tartrate | Intervention Type: DRUG; Name: Pimavanserin tartrate; Assigned to Arm(s): Pimavanserin 40 mg | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Improving Quality of Life in Nursing Home Residents: A Cluster Randomized Clinical Trial of Efficacy (The KOSMOS Study)
Brief Summary: Improving quality of life (QoL) in residents of nursing homes:

A cluster randomized clinical trial of efficacy - The KOSMOS study.

COSMOS (COmmunication (Advance Care Planning - ACP), Systematic pain assessment and treatment, Medication review, Occupational therapy, and Safety) is a practical intervention aimed to improve clinical and psychiatric challenges in NH patients. The COSMOS intervention combines the most effective research results to improve staff competence and patients' mental health, safety, QoL. We also aim to reduce psychotropic drug use and costs.


Options:
A: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Intervention; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Communication, Behavioral: Systematic Pain Assessment and Treatment, Behavioral: Medication Review, Behavioral: Occupational therapy, Behavioral: Safety | Intervention Type: BEHAVIORAL; Name: Communication; Assigned to Arm(s): Intervention | Intervention Type: BEHAVIORAL; Name: Systematic Pain Assessment and Treatment; Assigned to Arm(s): Intervention | Intervention Type: BEHAVIORAL; Name: Medication Review; Assigned to Arm(s): Intervention | Intervention Type: BEHAVIORAL; Name: Occupational therapy; Assigned to Arm(s): Intervention | Intervention Type: BEHAVIORAL; Name: Safety; Assigned to Arm(s): Intervention
B: Intervention Type: PROCEDURE; Name: family conference with bereavement information leaflet; Assigned to Arm(s): N/A
C: Arm Label: Booklet-Question List (BQL) group; Type: N/A; Interventions: Other: Booklet-Question List | Arm Label: control group; Type: N/A; Interventions: N/A | Intervention Type: OTHER; Name: Booklet-Question List; Assigned to Arm(s): Booklet-Question List (BQL) group
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Decision support skills building Intervention | Intervention Type: BEHAVIORAL; Name: Decision support skills building Intervention; Assigned to Arm(s): 1

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Improving Quality of Life in Nursing Home Residents: A Cluster Randomized Clinical Trial of Efficacy (The KOSMOS Study)
Brief Summary: Improving quality of life (QoL) in residents of nursing homes:

A cluster randomized clinical trial of efficacy - The KOSMOS study.

COSMOS (COmmunication (Advance Care Planning - ACP), Systematic pain assessment and treatment, Medication review, Occupational therapy, and Safety) is a practical intervention aimed to improve clinical and psychiatric challenges in NH patients. The COSMOS intervention combines the most effective research results to improve staff competence and patients' mental health, safety, QoL. We also aim to reduce psychotropic drug use and costs.


Options:
A: Arm Label: I; Type: EXPERIMENTAL; Interventions: Other: Drug review 80+ -To reduce usage of hospital care | Arm Label: C; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Drug review 80+ -To reduce usage of hospital care; Assigned to Arm(s): I
B: Arm Label: Arm 1 - Intervention; Type: EXPERIMENTAL; Interventions: Other: Arm 1 Education Session | Arm Label: Arm 2 - Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Arm 1 Education Session; Assigned to Arm(s): Arm 1 - Intervention
C: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Intervention; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Communication, Behavioral: Systematic Pain Assessment and Treatment, Behavioral: Medication Review, Behavioral: Occupational therapy, Behavioral: Safety | Intervention Type: BEHAVIORAL; Name: Communication; Assigned to Arm(s): Intervention | Intervention Type: BEHAVIORAL; Name: Systematic Pain Assessment and Treatment; Assigned to Arm(s): Intervention | Intervention Type: BEHAVIORAL; Name: Medication Review; Assigned to Arm(s): Intervention | Intervention Type: BEHAVIORAL; Name: Occupational therapy; Assigned to Arm(s): Intervention | Intervention Type: BEHAVIORAL; Name: Safety; Assigned to Arm(s): Intervention
D: Arm Label: Educational intervention; Type: EXPERIMENTAL; Interventions: Behavioral: knowledge transfer tool | Arm Label: Wait-list group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: knowledge transfer tool; Assigned to Arm(s): Educational intervention

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Improving Quality of Life in Nursing Home Residents: A Cluster Randomized Clinical Trial of Efficacy (The KOSMOS Study)
Brief Summary: Improving quality of life (QoL) in residents of nursing homes:

A cluster randomized clinical trial of efficacy - The KOSMOS study.

COSMOS (COmmunication (Advance Care Planning - ACP), Systematic pain assessment and treatment, Medication review, Occupational therapy, and Safety) is a practical intervention aimed to improve clinical and psychiatric challenges in NH patients. The COSMOS intervention combines the most effective research results to improve staff competence and patients' mental health, safety, QoL. We also aim to reduce psychotropic drug use and costs.


Options:
A: Arm Label: Intervention; Type: OTHER; Interventions: Other: E-learning | Arm Label: Control; Type: OTHER; Interventions: Other: E-learning | Intervention Type: OTHER; Name: E-learning; Assigned to Arm(s): Control, Intervention
B: Arm Label: Pharmacist service,; Type: ACTIVE_COMPARATOR; Interventions: Other: Pharmacist service | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Pharmacist service; Assigned to Arm(s): Pharmacist service,
C: Arm Label: Standard care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Other: Interdisciplinary collaboration structure | Intervention Type: OTHER; Name: Interdisciplinary collaboration structure; Assigned to Arm(s): Intervention
D: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Intervention; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Communication, Behavioral: Systematic Pain Assessment and Treatment, Behavioral: Medication Review, Behavioral: Occupational therapy, Behavioral: Safety | Intervention Type: BEHAVIORAL; Name: Communication; Assigned to Arm(s): Intervention | Intervention Type: BEHAVIORAL; Name: Systematic Pain Assessment and Treatment; Assigned to Arm(s): Intervention | Intervention Type: BEHAVIORAL; Name: Medication Review; Assigned to Arm(s): Intervention | Intervention Type: BEHAVIORAL; Name: Occupational therapy; Assigned to Arm(s): Intervention | Intervention Type: BEHAVIORAL; Name: Safety; Assigned to Arm(s): Intervention

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Cluster-randomized, Non-inferiority Open-label Trial of the Impact of Supplementation Regimen on Consumption of Prenatal Calcium and Iron/Folic Acid Supplements and Adherence to Related Recommendations
Brief Summary: The World Health Organization (WHO) now recommends prenatal calcium supplementation for prevention of preeclampsia in populations with inadequate dietary intake. This study seeks to compare the effect of two dosing strategies on the amount of supplement ingested by pregnant women and adherence to related recommendations.


Options:
A: Arm Label: Meta Salud Diabetes-Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Education intervention | Arm Label: Meta Salud Diabetes-Comparison Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Education intervention; Assigned to Arm(s): Meta Salud Diabetes-Intervention
B: Arm Label: Regimen A; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Regimen A calcium and iron/folic acid | Arm Label: Regimen B; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Regimen B calcium and iron/folic acid | Intervention Type: DIETARY_SUPPLEMENT; Name: Regimen A calcium and iron/folic acid; Assigned to Arm(s): Regimen A | Intervention Type: DIETARY_SUPPLEMENT; Name: Regimen B calcium and iron/folic acid; Assigned to Arm(s): Regimen B
C: Arm Label: PrEP Prescription at Enrollment; Type: N/A; Interventions: N/A | Arm Label: No PrEP Prescription at Enrollment; Type: N/A; Interventions: N/A
D: Arm Label: ICC; Type: EXPERIMENTAL; Interventions: Other: Integrated collaborative care | Arm Label: E&R; Type: ACTIVE_COMPARATOR; Interventions: Other: Education and Resources | Intervention Type: OTHER; Name: Integrated collaborative care; Assigned to Arm(s): ICC | Intervention Type: OTHER; Name: Education and Resources; Assigned to Arm(s): E&R

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Cluster-randomized, Non-inferiority Open-label Trial of the Impact of Supplementation Regimen on Consumption of Prenatal Calcium and Iron/Folic Acid Supplements and Adherence to Related Recommendations
Brief Summary: The World Health Organization (WHO) now recommends prenatal calcium supplementation for prevention of preeclampsia in populations with inadequate dietary intake. This study seeks to compare the effect of two dosing strategies on the amount of supplement ingested by pregnant women and adherence to related recommendations.


Options:
A: Arm Label: ICC; Type: EXPERIMENTAL; Interventions: Other: Integrated collaborative care | Arm Label: E&R; Type: ACTIVE_COMPARATOR; Interventions: Other: Education and Resources | Intervention Type: OTHER; Name: Integrated collaborative care; Assigned to Arm(s): ICC | Intervention Type: OTHER; Name: Education and Resources; Assigned to Arm(s): E&R
B: Arm Label: PrEP Prescription at Enrollment; Type: N/A; Interventions: N/A | Arm Label: No PrEP Prescription at Enrollment; Type: N/A; Interventions: N/A
C: Arm Label: Regimen A; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Regimen A calcium and iron/folic acid | Arm Label: Regimen B; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Regimen B calcium and iron/folic acid | Intervention Type: DIETARY_SUPPLEMENT; Name: Regimen A calcium and iron/folic acid; Assigned to Arm(s): Regimen A | Intervention Type: DIETARY_SUPPLEMENT; Name: Regimen B calcium and iron/folic acid; Assigned to Arm(s): Regimen B
D: Arm Label: Meta Salud Diabetes-Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Education intervention | Arm Label: Meta Salud Diabetes-Comparison Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Education intervention; Assigned to Arm(s): Meta Salud Diabetes-Intervention

Answer: C